Also named in Dow Jones Sustainability Asia Pacific Index for 10th Consecutive Year

Achieved more than double the average pharmaceutical industry sustainability score

Demonstrated significant year-over-year growth in score for strategy to improve access to medicines

OSAKA, Japan-Thursday 19 September 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has been named in the 2019 Dow Jones Sustainability World Index, achieving more than double the average overall industry score. In addition, Takeda was named for the 10th consecutive year in the Dow Jones Sustainability Asia Pacific Index. The Dow Jones Sustainability Indices are an independent indication of the Company’s strong corporate environmental, social and governance (ESG) performance.

“Takeda’s commitment to creating and preserving value through environmental, social and governance initiatives is an important part of our role as a patient-centric and values-based global biopharmaceutical leader,” said Christophe Weber, President and CEO. “We understand the significance of sustainable business practices, and we are proud to be recognized for Takeda’s global impact and long-term commitment to building a brighter future.”

Takeda achieved more than double the average pharmaceutical industry sustainability score. Its strong scores in climate strategy and eco-efficiency support Takeda’s approach that a proactive environmental program focused on reducing environmental impacts leads to tangible economic benefits. Takeda also achieved double-digit year-over-year growth in its score for access to medicines – more than triple the industry average – based on its strategies to help strengthen evolving healthcare systems and tackle barriers that limit patient access.

In addition to Dow Jones World and Asia Pacific Indices, Takeda has been selected by multiple benchmark ESG indices and recognitions:

Name of
Index or Rating
    

Company/
Organization
    

Country
    

History of
Inclusion

FTSE4Good Developed Index
    

FTSE Russell
    

UK
    

15th consecutive year

MSCI ESG Leaders Index
    

MSCI
    

U.S.
    

10th consecutive year

Ethibel EXCELLENCE Investment
Register
    

Forum Ethibel
    

BEL
    

From July 2017

Prime Status
    

ISS-Oekom
    

GER
    

2nd consecutive year

Industry Mover Sustainability Yearbook
Award 2019
    

RobecoSAM
    

CHE
    

From February 2019

Global 100 Most Sustainable
Corporations in the World Index
    

Corporate Knights
    

CND
    

4th consecutive year

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Rare Diseases, and Neuroscience. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.
For more information, visit www.takeda.com

About Takeda’s Sustainable Value Report

Takeda’s annual Sustainable Value Report showcases how the company is addressing the world’s biggest challenges to sustainable development over the long-term. Data included are primarily non-financial, focusing on Takeda’s diverse CSR/ESG (sustainability) commitments, as well as how CSR/ESG priorities are inextricably linked to the company’s DNA. Takeda leverages such benchmarks as the international integrated reporting framework of the International Integrated Reporting Council (IIRC), United Nations Global Compact’s advanced level assessment criteria, and Global Reporting Initiative (GRI) Standards to create a comprehensive report that incorporates high standards of transparency and disclosure, targeting a broad range of stakeholders.
For more information, visit https://www.takeda.com/corporate-responsibility/Sustainable-Value-Report/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190918006069/en/

Contacts

Media Contact:
Kazumi Kobayashi
kazumi.kobayashi@takeda.com
+81 (0) 3-3278-2095

Permalink : https://www.aetoswire.com/news/takeda-recognized-in-the-2019-dow-jones-sustainability-world-index/en